The Drivers of Growth for MariMed (MRMD) | Interview with Bob Fireman, CEO

With a national footprint in 5 states, MariMed (MRMD) has had 11 consecutive quarters of revenue growth and positive EBITDA growth in 6 of the past 7 quarters. Looking at strategic growth and focused on consolidation and expansion, MariMed offers a full range of cannabis products. CEO Bob Fireman joined us to provide insights on the company.

00:00 Intro
00:48 MariMed’s growth (Revenue and EBITDA)
02:46 Massachusetts Operations
04:12 Region with the most Potential
05:49 Number of States to Operate In
07:00 Plans for Cash
08:52 Managed Client Based Businesses
10:42 Organic Growth
11:52 Product Formats and Long-Term Growth

 

0 0 votes
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Capital 10X gets down to the real money business, actionable financial insights for traders and investors. We analyze company earnings, interview management teams and help teach the fundamentals of financial analysis and options trading. Our mission is to hunt for genuine 10 baggers.
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments